Skip to main content
Clinical Trials/ACTRN12623001310651
ACTRN12623001310651
Recruiting
未知

Assisted Reproductive Technology use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders (ARTiMS): A prospective, longitudinal study.

John Hunter Hospital of the Hunter New England Local Health District0 sites25 target enrollmentDecember 15, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Pregnancy
Sponsor
John Hunter Hospital of the Hunter New England Local Health District
Enrollment
25
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 15, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
John Hunter Hospital of the Hunter New England Local Health District

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria are women who:
  • 1\) Have been diagnosed with MS or NMOSD
  • 2\) Who are planning to use ART to fall pregnant within 3 years of study start
  • 3\) Who attend one of the 8 MS specialist centres who use MSBase.
  • 4\) Who are \>18 years of age and \<55 years of age

Exclusion Criteria

  • 1\) Women who fall pregnant by means other than ART.
  • 2\) Male genetic sex

Outcomes

Primary Outcomes

Not specified

Similar Trials